Peter Goodfellow

Ordförande på

Gammadelta Therapeutics Ltd.

74 år

76 relationer

Health Technology

Consumer Services

Commercial Services

Profil

Peter Goodfellow is currently the Chairman at Gammadelta Therapeutics Ltd., Adaptate Biotherapeutics Ltd., and Senior Advisor at Abingworth LLP.
Previously, he held positions as Director at deCODE genetics, Inc., Director at The Institute of Cancer Research: Royal Cancer Hospital, Director-Supervisory Board at Prosensa Holding NV, Director at Muscular Dystrophy Campaign Ltd., and Director at Virion Biotherapeutics Ltd. He also served as Senior Vice President-Discovery Research at GSK Plc and as a Professor at the University of Cambridge.
Dr. Goodfellow obtained a doctorate degree from the University of Oxford and completed undergraduate and doctorate degrees at the University of Bristol.

Aktiva positioner av Peter Goodfellow

Företag	Position	Start
Gammadelta Therapeutics Ltd. Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer	Ordförande	-
Adaptate Biotherapeutics Ltd. Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology	Ordförande	-
Abingworth LLP Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million.	Konsult / Rådgivare	-

Alla aktiva positioner av Peter Goodfellow

Tidigare kända positioner av Peter Goodfellow

Företag	Position	Slut
GENSIGHT BIOLOGICS S.A.	Direktör/Styrelseledamot	2023-06-21
deCODE genetics, Inc. deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company	Direktör/Styrelseledamot	2010-07-13
GSK PLC	Teknisk/Vetenskaplig/F&U Direktör	-
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Företagsledare/Principal	-
Virion Biotherapeutics Ltd. Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Engages in research in biotechnology for developing therapies for respiratory viral infections	Direktör/Styrelseledamot	-

Se detaljerna i Peter Goodfellows erfarenhet

Peter Goodfellows utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Peter Goodfellows erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	13
deCODE genetics, Inc. deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company	Health Technology
The Institute of Cancer Research: Royal Cancer Hospital The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services Operates as a cancer research institution	Commercial Services
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
Abingworth LLP Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million.	Finance
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Bristol University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Prosensa Holding NV Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders	Health Technology
Muscular Dystrophy Campaign Ltd.
Gensight Biologics SA Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases	Health Technology
Gammadelta Therapeutics Ltd. Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer	Health Technology
Virion Biotherapeutics Ltd. Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Engages in research in biotechnology for developing therapies for respiratory viral infections	Health Technology
Adaptate Biotherapeutics Ltd. Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology	Commercial Services